June 17, 2011 — The U.S. Food and Drug Administration (FDA) said Boston Scientific has issued a class I recall for its Innova Over-the-Wire Self-Expanding Stent System, because of complaints of no or partial deployments.

June 17, 2011 — KLAS today announced the release of their highly anticipated "2011 Top 20 Best in KLAS Awards: Medical Equipment & Infrastructure" report. The awards are based on data from customer surveys of hospital and clinic executives, administrators, physicians, nurses, clinicians, and other directors and managers interacting with healthcare equipment and infrastructure solutions.

June 17, 2011 – In hybrid operating rooms (OR), healthcare facilities require a flexible imaging system to create a collaborative environment between clinicians and to allow both surgical and interventional procedures to be performed in one setting. At this year’s Society of Vascular Surgery (SVS) annual meeting, held in Chicago, June 16-18, Toshiba America Medical Systems, Inc. will highlight single-plane, ceiling-mounted Infinix-i X-ray systems and their compatibility with the Toshiba CAT-880B hybrid table and the Maquet Magnus OR table.

June 17, 2011 — Endologix, Inc. announced it received U.S. Food and Drug Administration (FDA) approval for AFX Endovascular AAA System for the treatment of abdominal aortic aneurysms (AAA). The company is introducing AFX at the annual meeting of the Society for Vascular Surgery (SVS), which is taking place June 16-18, 2011 in Chicago.

June 17, 2011 – The new Pathfast cTnI-II (cardiac troponin I) test from Mitsubishi Chemical Medience Corporation has been granted 510(k) premarketing notification clearance by the U.S. Food and Drug Administration (FDA), clearing it for sale in the United States.

June 16, 2011 — More than 5,500 physicians, technologists, physicists, scientists and exhibitors gathered last week at the Society of Nuclear Medicine's (SNM) 2011 annual meeting, held June 4-8 in San Antonio, Texas.

Cordis announced it will cease production of the Cypher sirolimus-eluting stent, the first drug-eluting stent (DES) to secure U.S. Food and Drug Administration (FDA) approval, by the end of 2011. The company will also halt production of the Cypher Select Plus as well as development of the Nevo sirolimus DES.

June 15, 2011 – The U.S. Food and Drug Administration (FDA) said Terumo Cardiovascular Systems Corp. has issued a class I recall for its Coronary Ostia Cannula 10 (25 cm) long. The company said foreign fragments of adhesive and plastic in the cannula tip may embolize, causing arterial injury, hemorrhaging or other serious events requiring unplanned surgery.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now